STOCK TITAN

Fractyl Health (GUTS) CEO buys 25,000 open-market shares

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Fractyl Health, Inc. Chief Executive Officer Harith Rajagopalan reported an open-market purchase of 25,000 shares of common stock on June 10, 2026 at a weighted average price of $0.7301 per share, with trade prices ranging from $0.7213 to $0.7324.

Following this transaction, he directly holds 540,557 shares of common stock and indirectly holds additional shares through three trusts with reported positions of 18,639, 292,170, and 292,171 shares. His holdings also include 13,812 shares purchased under the company’s 2024 Employee Stock Purchase Plan on January 30, 2026 at $0.391 per share.

Positive

  • None.

Negative

  • None.
Insider Rajagopalan Harith
Role Chief Executive Officer
Bought 25,000 shs ($18K)
Type Security Shares Price Value
Purchase Common Stock 25,000 $0.7301 $18K
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 540,557 shares (Direct, null); Common Stock — 292,171 shares (Indirect, By 2021 Irrevocable Trust)
Footnotes (1)
  1. Open market purchase. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7213 to $0.7324, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Includes 13,812 shares of common stock purchased pursuant to the Issuer's 2024 Employee Stock Purchase Plan (ESPP) on January 30, 2026, at a purchase price of $0.391 per share.
Open-market purchase 25,000 shares Common Stock bought on June 10, 2026
Weighted average purchase price $0.7301 per share Open-market buy on June 10, 2026
Trade price range $0.7213–$0.7324 per share Range for June 10, 2026 purchases
Direct holdings after transaction 540,557 shares Common Stock directly owned post-purchase
2021 Family Trust holdings 18,639 shares Indirect ownership reported as of June 10, 2026
2016 Irrevocable Trust holdings 292,170 shares Indirect ownership reported as of June 10, 2026
2021 Irrevocable Trust holdings 292,171 shares Indirect ownership reported as of June 10, 2026
ESPP purchase 13,812 shares at $0.391 2024 ESPP on January 30, 2026
Open market purchase financial
"Open market purchase."
An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Employee Stock Purchase Plan (ESPP) financial
"purchased pursuant to the Issuer's 2024 Employee Stock Purchase Plan (ESPP)"
irrevocable trust financial
"By 2016 Irrevocable Trust"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
Family Trust financial
"By 2021 Family Trust"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rajagopalan Harith

(Last)(First)(Middle)
3 VAN DE GRAAFF DRIVE
SUITE 200

(Street)
BURLINGTON MASSACHUSETTS 01803

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
FRACTYL HEALTH, INC. [ GUTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/10/2026P(1)25,000A$0.7301(2)540,557(3)D
Common Stock292,171IBy 2021 Irrevocable Trust
Common Stock292,170IBy 2016 Irrevocable Trust
Common Stock18,639IBy 2021 Family Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Open market purchase.
2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7213 to $0.7324, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
3. Includes 13,812 shares of common stock purchased pursuant to the Issuer's 2024 Employee Stock Purchase Plan (ESPP) on January 30, 2026, at a purchase price of $0.391 per share.
/s/ Harith Rajagopalan, M.D., Ph.D06/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Fractyl Health (GUTS) report for its CEO?

Fractyl Health (GUTS) reported that CEO Harith Rajagopalan bought 25,000 shares of common stock in an open-market transaction. The trade occurred on June 10, 2026 at a weighted average price of $0.7301 per share, indicating a direct cash purchase rather than a stock grant.

At what prices did the Fractyl Health (GUTS) CEO buy his 25,000 shares?

The CEO’s 25,000 Fractyl Health (GUTS) shares were purchased at a weighted average price of $0.7301 per share. According to the filing, individual trades took place within a range of $0.7213 to $0.7324 per share during the open-market buying activity.

How many Fractyl Health (GUTS) shares does the CEO own after this transaction?

After the reported purchase, the Fractyl Health (GUTS) CEO directly owns 540,557 common shares. The filing also lists indirect holdings through several trusts, with reported positions of 18,639, 292,170, and 292,171 shares, providing a fuller picture of his overall share exposure.

What indirect Fractyl Health (GUTS) holdings are reported for the CEO?

The filing shows that the Fractyl Health (GUTS) CEO has indirect ownership through three trusts. These trusts report holdings of 18,639 shares by a 2021 Family Trust, 292,170 shares by a 2016 Irrevocable Trust, and 292,171 shares by a 2021 Irrevocable Trust.

What Employee Stock Purchase Plan activity is disclosed for Fractyl Health (GUTS)?

The filing notes that the CEO’s holdings include 13,812 Fractyl Health (GUTS) shares acquired under the 2024 Employee Stock Purchase Plan. These ESPP shares were purchased on January 30, 2026 at a price of $0.391 per share, contributing to his overall ownership.

Was the CEO’s Fractyl Health (GUTS) transaction a purchase or sale?

The CEO’s Fractyl Health (GUTS) Form 4 transaction was a purchase, coded as an open-market buy. He acquired 25,000 common shares, increasing his direct holdings to 540,557 shares according to the post-transaction ownership reported in the filing.